Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas - A Prospective Multicenter Parallel Group Clinical Trial

NCT02379572 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT02379572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02379572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas - A Prospective Multicenter Parallel Group Clinical Trial
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
July 1, 2021
Enrollment
315 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma